BIO-Europe
10-03-01 Update: we’re keeping an eye on EBD’s offerings for the upcoming year, but you have any more recent or more accurate information, don’t hesitate to drop us a note!
BIO-Europe Spring 2010 begins one week from now (March 8-10, 2010), at the CCIB (Centre Convencions International Barcelona). In addition to empowering partnerships and developing life science business models, the topics cover a wide range of business-focused directed discussions, mainly in the bio-pharma fields.
Bio€quity Europe 2010: Zurich will again be hosting this forum, now in its second decade, for venture capitalists, public markets investors, and life science companies (public and late-stage private). May 19-20 is the date, so there’s still some time to get your plans together!
EuroMedtech 2010: On June 1-2, Leipzig, Germany will host the major European conference specifically for medical technology interests, bringing together innovators and investors as well as related essential companies from legal to distribution.
ChinaBio Partering Forum 2010: Suzhou will be the destination for the second ChinaBio, offering unique opportunities for biopharma and biotech networking among opportunistic strategists. June 23-24 is not as far away as it seems right now!
BioPharm America 2010: On September 15-17, the third installment of the Yankee version of BIO-Europe will see plenty of partnering and networking among biopharma interests. Boston at the beginning of autumn is not to be missed.
BIO-Europe 2010: This is the big one, of course. November 15-17 in Munich is Ground Zero for Europe’s (and indeed, the world’s) top biotech firms. Partnering and rhetoric will reach unheard-of heights, possibly surpassing 2009′s amazing 12,504 one-to-one meetings. Hopefully, this year will have more rousing debates (such as 2009′s “Will US Healthcare Reform Hasten the Apocalypse?”)
Biotech Showcase 2011: with the echoes of the first Showcase barely dying down, it’s not too early to prepare for San Francisco’s second major biopharma partnering forum. Tentative schedules are already coming together, though no set dates have been posted yet.
Still undetermined is the commitment if any to medical tourism as a revenue source. We strongly suggest you keep an eye on this new field with respect to opportunities and growth that will impact all players.
No responses yet